|
1
|
Shaffer EA: Gallbladder cancer: The
basics. Gastroenterol Hepatol (N Y). 4:737–741. 2008.PubMed/NCBI
|
|
2
|
Sachs TE, Akintorin O and Tseng J: How
should gallbladder cancer be managed? Adv Surg. 52:89–100. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kakaei F, Beheshtirouy S, Nejatollahi SM,
Zarrintan S and Mafi MR: Surgical treatment of gallbladder
carcinoma: A critical review. Updates Surg. 67:339–351. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lazcano-Ponce EC, Miquel JF, Munoz N,
Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista
G and Nervi F: Epidemiology and molecular pathology of gallbladder
cancer. CA Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Misra S, Chaturvedi A, Misra NC and Sharma
ID: Carcinoma of the gallbladder. Lancet Oncol. 4:167–176. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Patop IL and Kadener S: circRNAs in
cancer. Curr Opin Genet Dev. 48:121–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo JU, Agarwal V, Guo H and Bartel DP:
Expanded identification and characterization of mammalian circular
RNAs. Genome Biol. 15:4092014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song R, Li Y, Hao W, Yang L, Chen B, Zhao
Y, Sun B and Xu F: Circular RNA MTO1 inhibits gastric cancer
progression by elevating PAWR via sponging miR-199a-3p. Cell Cycle.
19:3127–3139. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ge Z, Li LF, Wang CY, Wang Y and Ma WL:
circMTO1 inhibits cell proliferation and invasion by regulating
Wnt/β-catenin signaling pathway in colorectal cancer. Eur Rev Med
Pharmacol Sci. 22:8203–8209. 2018.PubMed/NCBI
|
|
10
|
Li Y, Wan B, Liu L, Zhou L and Zeng Q:
Circular RNA circMTO1 suppresses bladder cancer metastasis by
sponging miR-221 and inhibiting epithelial-to-mesenchymal
transition. Biochem Biophys Res Commun. 508:991–996. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang X, Zhong B, Zhang W, Wu J and Wang
Y: Circular RNA circMTO1 inhibits proliferation of glioblastoma
cells via miR-92/WWOX signaling pathway. Med Sci Monit.
25:6454–6461. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Lin YK, Lu ZL and Li J: Circular
RNA circ-MTO1 serves as a novel potential diagnostic and prognostic
biomarker for gallbladder cancer. Eur Rev Med Pharmacol Sci.
24:8359–8366. 2020.PubMed/NCBI
|
|
13
|
Shi CC, Pan LY, Peng ZY and Li JG:
circMTO1 attenuated acute kidney injury through regulating miR-337.
Inflammation. 43:1304–1311. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Braicu C, Zimta AA, Harangus A, Iurca I,
Irimie A, Coza O and Berindan-Neagoe I: The function of non-coding
RNAs in lung cancer tumorigenesis. Cancers (Basel). 11:6052019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boufraqech M, Nilubol N, Zhang L, Gara SK,
Sadowski SM, Mehta A, He M, Davis S, Dreiling J, Copland JA, et al:
miR30a inhibits LOX expression and anaplastic thyroid cancer
progression. Cancer Res. 75:367–377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rao C, Miao X, Zhao G, Zhang C, Shen H,
Dong C and Yang M: miR-219a-5p enhances cisplatin sensitivity of
human non-small cell lung cancer by targeting FGF9. Biomed
Pharmacother. 114:1086622019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu K, Shi J, Mo D, Yang Y, Fu Q and Luo Y:
miR-219a-1 inhibits colon cancer cells proliferation and invasion
by targeting MEMO1. Cancer Biol Ther. 21:1163–1170. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei T, Cheng S, Fu XN and Feng LJ:
miR-219a-5p enhances the radiosensitivity of non-small cell lung
cancer cells through targeting CD164. Biosci Rep.
40:BSR201927952020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan J, Bu X, Li Z, Wu J, Wang C, Li D,
Song J and Wang J: Screening the expression of several miRNAs from
TaqMan low density array in traumatic brain injury: miR-219a-5p
regulates neuronal apoptosis by modulating CCNA2 and CACUL1. J
Neurochem. 150:202–217. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maruyama T, Nishihara K, Umikawa M,
Arasaki A, Nakasone T, Nimura F, Matayoshi A, Takei K, Nakachi S,
Kariya KI and Yoshimi N: MicroRNA-196a-5p is a potential prognostic
marker of delayed lymph node metastasis in early-stage tongue
squamous cell carcinoma. Oncol Lett. 15:2349–2363. 2018.PubMed/NCBI
|
|
22
|
Chen M, Ai G, Zhou J, Mao M, Li H and Guo
J: circMTO1 promotes tumorigenesis and chemoresistance of cervical
cancer via regulating miR-6893. Biomed Pharmacother.
117:1090642019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li R, Jiang J, Shi H, Qian H, Zhang X and
Xu W: circRNA: A rising star in gastric cancer. Cell Mol Life Sci.
77:1661–1680. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan Z, Xiao Y, Chen Y and Luo G: Screening
and identification of epithelial-to-mesenchymal transition-related
circRNA and miRNA in prostate cancer. Patho Res Pract.
216:1527842020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang X, He M, Huang S, Lin R, Zhan M,
Yang D, Shen H, Xu S, Cheng W, Yu J, et al: Circular RNA circERBB2
promotes gallbladder cancer progression by regulating
PA2G4-dependent rDNA transcription. Mol Cancer. 18:1662019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kai D, Yannian L, Yitian C, Dinghao G, Xin
Z and Wu J: Circular RNA HIPK3 promotes gallbladder cancer cell
growth by sponging microRNA-124. Biochem Biophys Res Commun.
503:863–869. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang S, Zhang Y, Cai Q, Ma M, Jin LY, Weng
M, Zhou D, Tang Z, Wang JD and Quan Z: Circular RNA FOXP1 promotes
tumor progression and Warburg effect in gallbladder cancer by
regulating PKLR expression. Mol Cancer. 18:1452019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Tan Q, Wang W and Yu J: Mechanism
of the regulatory effect of overexpression of circMTO1 on
proliferation and apoptosis of hepatoma cells via miR-9-5p/NOX4
axis. Cancer Manag Res. 12:3915–3925. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kristensen LS, Hansen TB, Veno MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA circMTO1 acts as
the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 66:1151–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Long J, Menggen Q, Wuren Q, Shi Q and Pi
X: miR-219-5p inhibits the growth and metastasis of malignant
melanoma by targeting BCL-2. Biomed Res Int. 2017:90325022017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bao RF, Shu YJ, Hu YP, Wang XA, Zhang F,
Liang HB, Ye YY, Li HF, Xiang SS, Weng H, et al: miR-101 targeting
ZFX suppresses tumor proliferation and metastasis by regulating the
MAPK/Erk and Smad pathways in gallbladder carcinoma. Oncotarget.
7:22339–22354. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qiu Y, Luo X, Kan T, Zhang Y, Yu W, Wei Y,
Shen N, Yi B and Jiang X: TGF-β upregulates miR-182 expression to
promote gallbladder cancer metastasis by targeting CADM1. Mol
Biosyst. 10:679–685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Syed V: TGF-β signaling in cancer. J Cell
Biochem. 117:1279–1287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang L, Yu M and Zhao S: lncRNA MEG3
modified epithelial-mesenchymal transition of ovarian cancer cells
by sponging miR-219a-5p and regulating EGFR. J Cell Biochem.
120:17709–17722. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen H, He M, Lin R, Zhan M, Xu S, Huang
X, Xu C, Chen W, Yao Y, Mohan M and Wang J: PLEK2 promotes
gallbladder cancer invasion and metastasis through EGFR/CCL2
pathway. J Exp Clin Cancer Res. 38:2472019. View Article : Google Scholar : PubMed/NCBI
|
